--- title: "Gregg C Newman, M.D. | Sutter Health" url: "https://www.sutterhealth.org/research/investigators/gregg-c-newman-md-1097247316" --- 1. [Home](https://www.sutterhealth.org/) / 2. [Research](https://www.sutterhealth.org/research) / 3. [Investigators](https://www.sutterhealth.org/research/investigators) / 4. Gregg C Newman, M.D. ![Gregg C Newman, M.D.](https://dyn.mktgcdn.com/p/eVDt8GBNHJ0QudFYw0aWoA_xvD35pHM1Hir7WCNnYKk/fit=crop,gravity=auto,dpr=2,width=240,height=240) # Gregg C Newman, M.D. Investigator [View profile](https://www.sutterhealth.org/find-provider/dr-gregg-c-newman-1090093416) Dr. Gregg C. Newman is a board-certified medical oncologist and hematologist with over two decades of clinical and research experience. He has been practicing at Sansum Clinic in Santa Barbara, California since 1999 and provides care at the Ridley-Tree Cancer Center. Dr. Newman has been actively involved in clinical research since 2000, serving as a clinical trial investigator with national cooperative groups including SWOG and NSABP, and participating on the Santa Barbara Cottage Hospital Research Committee. He completed his fellowship in hematology and oncology at Cornell Medical School, with additional training at Memorial Sloan Kettering Cancer Center. Dr. Newman earned his medical degree from Mount Sinai Medical School and completed his internal medicine residency at the University of California, Davis. His work includes published research in hematology and oncology, reflecting his ongoing commitment to advancing cancer care and improving patient outcomes. ## Clinical trials - Clinical trial ### [Advanced Solid Tumors CA239-0008](https://www.sutterhealth.org/research/clinical-trials/advanced-solid-tumors-ca239-0008-2022933799) A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients With Advanced Solid Tumors With KRAS G12C Mutation KRYSTAL-1 **Status:** Open to Enrollment - Clinical trial ### [Metastatic Castration Resistant Prostate Cancer CAAA817B12301 ActFirst](https://www.sutterhealth.org/research/clinical-trials/metastatic-castration-resistant-prostate-cancer-caaa817b12301-actfirst-2045398589) A Phase III, Open-label, Multi-center, Randomized Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive Metastatic Castration Resistant Prostate Cancer **Status:** Open to Enrollment - Clinical trial ### [Metastatic Prostate Cancer BNT325-03](https://www.sutterhealth.org/research/clinical-trials/metastatic-prostate-cancer-bnt325-03-2097344194) A Phase III, Randomized, Open-label Trial of BNT324 Versus Docetaxel With Prednisone/Prednisolone in Metastatic Castration-resistant Prostate Cancer **Status:** Open to Enrollment - Clinical trial ### [Metastatic Prostate Cancer PSMAcTION CAAA817A12201](https://www.sutterhealth.org/research/clinical-trials/metastatic-prostate-cancer-psmaction-caaa817a12201-2097344168) PSMAcTION: A Phase II/III, Open-label, International, Multicenter, Randomized Study of AAA817 Versus Standard of Care in the Treatment of Adult Participants With PSMA Positive Metastatic Castration-resistant Prostate Cancer Who Progressed on or After \[177Lu\]Lu-PSMA Targeted Therapy **Status:** Open to Enrollment ```json {"@context":"https://schema.org","@type":"MedicalOrganization","name":"Sutter Health","@id":"https://www.sutterhealth.org/#medicalorganization","url":"https://www.sutterhealth.org","logo":"https://www.sutterhealth.org/static/images/sutter-health-logo.svg","address":{"@type":"PostalAddress","streetAddress":"2200 River Plaza Drive","addressLocality":"Sacramento","addressRegion":"CA","postalCode":"95833","addressCountry":"US"},"areaServed":{"@type":"AdministrativeArea","name":"California"},"sameAs":["https://www.facebook.com/SutterHealth","https://www.instagram.com/sutterhealth/","https://x.com/SutterHealth","https://www.youtube.com/sutterhealth","https://www.linkedin.com/company/sutter-health","https://en.wikipedia.org/wiki/Sutter_Health"]} ``` ```json {"@context":"https://schema.org","@type":"BreadcrumbList","@id":"https://www.sutterhealth.org/research/investigators/gregg-c-newman-md-1097247316#breadcrumblist","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://www.sutterhealth.org/"},{"@type":"ListItem","position":2,"name":"Research","item":"https://www.sutterhealth.org/research"},{"@type":"ListItem","position":3,"name":"Investigators","item":"https://www.sutterhealth.org/research/investigators"},{"@type":"ListItem","position":4,"name":"Gregg C Newman, M.D."}]} ``` ```json {"@context":"https://schema.org","@type":"ProfilePage","@id":"https://www.sutterhealth.org/research/investigators/gregg-c-newman-md-1097247316#profilepage","url":"https://www.sutterhealth.org/research/investigators/gregg-c-newman-md-1097247316","name":"Gregg C Newman, M.D.","dateModified":"2026-06-04","breadcrumb":{"@id":"https://www.sutterhealth.org/research/investigators/gregg-c-newman-md-1097247316#breadcrumblist"},"primaryImageOfPage":{"@type":"ImageObject","contentUrl":"https://a.mktgcdn.com/p/eVDt8GBNHJ0QudFYw0aWoA_xvD35pHM1Hir7WCNnYKk/460x460.webp","width":460,"height":460},"mainEntity":{"@id":"https://www.sutterhealth.org/research/investigators/gregg-c-newman-md-1097247316"}} ``` ```json {"@context":"https://schema.org","@type":"Person","@id":"https://www.sutterhealth.org/research/investigators/gregg-c-newman-md-1097247316","name":"Gregg C Newman, M.D.","givenName":"Gregg","additionalName":"C","familyName":"Newman","honorificSuffix":"M.D.","description":"Dr. Gregg C. Newman is a board-certified medical oncologist and hematologist with over two decades of clinical and research experience. He has been practicing at Sansum Clinic in Santa Barbara, California since 1999 and provides care at the Ridley-Tree Cancer Center. Dr. Newman has been actively involved in clinical research since 2000, serving as a clinical trial investigator with national cooperative groups including SWOG and NSABP, and participating on the Santa Barbara Cottage Hospital Research Committee. He completed his fellowship in hematology and oncology at Cornell Medical School, with additional training at Memorial Sloan Kettering Cancer Center. Dr. Newman earned his medical degree from Mount Sinai Medical School and completed his internal medicine residency at the University of California, Davis. His work includes published research in hematology and oncology, reflecting his ongoing commitment to advancing cancer care and improving patient outcomes.","image":{"@type":"ImageObject","contentUrl":"https://a.mktgcdn.com/p/eVDt8GBNHJ0QudFYw0aWoA_xvD35pHM1Hir7WCNnYKk/460x460.webp","representativeOfPage":true},"affiliation":{"@id":"https://www.sutterhealth.org/#medicalorganization"},"mainEntityOfPage":{"@id":"https://www.sutterhealth.org/research/investigators/gregg-c-newman-md-1097247316#profilepage"},"sameAs":"https://www.sutterhealth.org/find-provider/dr-gregg-c-newman-1090093416"} ```